Insights | Healthcare | Canada | Global law firm | Norton Rose Fulbright Skip to main content
Norton Rose Fulbright logo
  • Canada
  • About
    • Our firm
      • Global coverage
      • Vision, culture and people
      • Alumni
    • Diversity, Equity & Inclusion
    • Accessibility
      • Accessible customer service policy
      • Accessibility plan
      • Accessibility policy
    • Responsible business
      • Social Impact
      • Pro bono
      • Sustainability
      • Responsible use of AI
  • People
  • Services
    • Services A-Z
    • Key industries
      • Consumer markets
      • Energy, infrastructure and resources
      • Financial institutions
      • Life sciences and healthcare
      • Technology
      • Transport
    • Practices
      • Antitrust and competition
      • Corporate, M&A and securities
      • Employment and labour
      • Financial services and regulation
      • Intellectual property
      • Litigation and disputes
      • Projects
      • Regulation and investigations
      • Risk advisory
      • Tax
      • Banking and finance
      • Cybersecurity and data privacy
      • Environmental, social and governance (ESG)
      • Fraud and asset recovery
      • International trade
      • Private equity and venture capital
      • Real estate
      • Restructuring
      • Special situations
      • White-collar, regulatory and investigations
    • NRF Transform
    • Transform image

      Find out more
  • Insights
    • Publications
    • Podcasts
    • Blogs
    • Webinars and events
    • Videos
    • Client work
    • Professional development
    • Resources and tools
    • Upward view of green corporate building
      Responsible Business
      and Sustainability

      Visit the hub
  • News
    • Press releases
    • In the media
    • Market recognitions
    • Media information
  • Locations
    • Calgary
    • Montréal
    • Ottawa
    • Québec
    • Toronto
    • Vancouver
    • Global coverage
  • Careers
  • Change
Norton Rose Fulbright logo

  1. Services
  2. Healthcare

Healthcare

Healthcare
Overview Insights People
Subscribe to our insights
    • Healthcare
    • Overview
    • Insights
    • People
    • Subscribe to our insights
  • Publication

    Mitigating tariff risks for healthcare in US and Canada

    The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

    April 21, 2025

    Healthcare
    Blue pills in a packaged strip

    Publication

    Newly licensed NHPs to be temporarily exempt from upcoming labelling requirements

    Health Canada has published a Notice of Intent to publish a ministerial order to exempt natural health products (NHPs) l...

    March 11, 2025

    Life sciences and pharmaceuticals
    Two doctors walking down the hallway of a hospital.

    Publication

    New rules for MDEL holders: Health Canada’s terms and conditions authority

    Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licenc...

    January 10, 2025

    Life sciences and pharmaceuticals
    88th Texas Legislature 2023 healthcare legislative update

    Publication

    Health Canada’s recall shake-up: Navigating mandatory orders and reporting requirements for medical devices

    New and clarified requirements for recalls under the Food and Drug Regulations and Medical Devices Regulations (MDR) are...

    January 9, 2025

    Life sciences and pharmaceuticals
    A doctor in a whitecoat holding a tablet in a hospital hallway

    Publication

    An update on Alberta’s Bill 26: Health Statutes Amendment Act

    Alberta’s Bill 26 seeks to continue the government’s restructuring of healthcare in Alberta and introduces prohibitions ...

    December 18, 2024

    Healthcare
    Mitigating Tariff Risks For Healthcare In US And Canada

    Publication

    Mitigating tariff risks for healthcare in US and Canada

    The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

    April 21, 2025

    Healthcare
    Blue pills in a packaged strip

    Publication

    Newly licensed NHPs to be temporarily exempt from upcoming labelling requirements

    Health Canada has published a Notice of Intent to publish a ministerial order to exempt natural health products (NHPs) l...

    March 11, 2025

    Life sciences and pharmaceuticals
    Two doctors walking down the hallway of a hospital.

    Publication

    New rules for MDEL holders: Health Canada’s terms and conditions authority

    Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licenc...

    January 10, 2025

    Life sciences and pharmaceuticals
    88th Texas Legislature 2023 healthcare legislative update

    Publication

    Health Canada’s recall shake-up: Navigating mandatory orders and reporting requirements for medical devices

    New and clarified requirements for recalls under the Food and Drug Regulations and Medical Devices Regulations (MDR) are...

    January 9, 2025

    Life sciences and pharmaceuticals
    A doctor in a whitecoat holding a tablet in a hospital hallway

    Publication

    An update on Alberta’s Bill 26: Health Statutes Amendment Act

    Alberta’s Bill 26 seeks to continue the government’s restructuring of healthcare in Alberta and introduces prohibitions ...

    December 18, 2024

    Healthcare
    More
    Subscribe to insights

    Subscribe to our insights

    Stay up to date with the latest publications, podcasts, webinars and events
    Subscribe

    © Norton Rose Fulbright LLP 2025

    Explore our site

    • About
    • Careers
    • Diversity, Equity & Inclusion
    • People
    • Services
    • Insights
    • News

    Key industries

    • Consumer markets
    • Energy, infrastructure and resources
    • Financial institutions
    • Life sciences and healthcare
    • Technology
    • Transport

    Locations

    • Calgary
    • Montréal
    • Ottawa
    • Québec
    • Toronto
    • Vancouver
    • Global coverage

    © Norton Rose Fulbright Canada LLP / S.E.N.C.R.L., s.r.l.

    • Legal notices and disclaimers
    • Standard terms
    • Impressum
    • Blog network terms and conditions
    • Privacy notice
    • Cookies policy
    • Website access conditions
    • Fraud alerts
    • Modern Slavery Statements
    • Anti-Facilitation of Tax Evasion Statement
    • Suppliers
    • History
    • Remote access
    • Sitemap
    Legal entity

    © Norton Rose Fulbright Canada LLP / S.E.N.C.R.L., s.r.l.

    Policies and disclaimers
    • Legal notices and disclaimers
    • Standard terms
    • Impressum
    • Blog network terms and conditions
    • Privacy notice
    • Cookies policy
    • Website access conditions
    • Fraud alerts
    • Modern Slavery Statements
    • Anti-Facilitation of Tax Evasion Statement
    • Suppliers
    • History
    • Remote access
    • Sitemap
    Visit our global site, or select a location
    North America
    • Canada (English)
    • Canada (Français)
    • United States
    Latin America
    • Brazil
    • Mexico
    Europe
    • Belgium
    • Deutschland (Deutsch)
    • France
    • Germany (English)
    • Greece
    • Italy
    • Luxembourg
    • Poland
    • The Netherlands
    • Türkiye
    • United Kingdom
    Middle East
    Africa
    • Burundi
    • Kenya
    • Morocco
    • South Africa
    • Uganda
    • Zimbabwe
    Asia Pacific
    • Australia
    • China
    • Hong Kong SAR
    • Indonesia
    • Japan
    • Singapore
    • Thailand
    Regional practices
    • India
    • Israel
    • Korea
    • Marshall Islands
    • Nordic region
    • Pakistan
    • Vietnam